| ◆英語タイトル：Global Equine Healthcare Market Size study & Forecast, by Product (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Diagnostics, Software & Services, Others), by Indication (Musculoskeletal Disorders, Parasite Control, Internal Medicine, Equine Herpes Virus, Equine Influenza, Others), by Activity (Sports/Racing, Recreation, Others), by Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Others), and Regional Analysis, 2022-2029
|
 | ◆商品コード：BZW23FE0131
◆発行会社（リサーチ会社）：Bizwit Research & Consulting
◆発行日：2023年1月29日
◆ページ数：約200
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
◆産業分野：医療
|
◆販売価格オプション
（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
Bizwit Research社は、2021年に約25億ドルであった世界の馬健康管理市場規模は、2022年から2029年の間にCAGR 6.1％増加すると予想しています。本書は、馬健康管理の世界市場について調査・分析を行い、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、製品別（ワクチン、医薬品、薬用飼料添加物、診断、その他）分析、疾患別（筋骨格系疾患、寄生虫防除、内科、馬ヘルペスウイルス、その他）分析、アクティビティ別（スポーツ/レース、レクリエーション、その他）分析、流通チャネル別（動物病院・診療所、Eコマース、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他地域）分析、競争分析、調査プロセスなどの内容をまとめています。また、本書で記載されている企業情報には、Zoetis Inc.、Boehringer Ingelheim International GmbH、Cev、SOUND、Merck & Co., Inc.、Hallmarq Veterinary Imaging、Esaote SPA、Vetoquinol S.A.、IDEXX Laboratories, Inc.、Dechra Pharmaceuticals PLCなどが含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界馬健康管理市場規模：製品別
- ワクチンの市場規模
- 医薬品の市場規模
- 薬用飼料添加物の市場規模
- 診断の市場規模
- その他馬健康管理の市場規模
・世界馬健康管理市場規模：疾患別
- 筋骨格系疾患における市場規模
- 寄生虫防除における市場規模
- 内科における市場規模
- 馬ヘルペスウイルスにおける市場規模
- その他疾患における市場規模
・世界馬健康管理市場規模：アクティビティ別
- スポーツ/レースにおける市場規模
- レクリエーションにおける市場規模
- その他活動における市場規模
・世界馬健康管理市場規模：流通チャネル別
- 動物病院・診療所チャネルの市場規模
- Eコマースチャネルの市場規模
- その他チャネルの市場規模
・世界の馬健康管理市場規模：地域別
- 北米の馬健康管理市場
- ヨーロッパの馬健康管理市場
- アジア太平洋の馬健康管理市場
- 中南米の馬健康管理市場
- その他地域の馬健康管理市場
・競争分析
・調査プロセス |
Global Equine Healthcare Market is valued at approximately USD 2.5 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2022-2029. Equine healthcare is medical care and related services that are provided to horses used for racing and wagering, competitive riding, and recreation. Equine healthcare encompasses regular veterinary treatment for immunizations, parasite management, and dental care, along with grooming and hoof care and protection from the elements including rain, wind, and snow. The growing prevalence of diseases in horses, and increasing requirements for equine diagnostics, coupled with rising government support are attributed to the market demand across the globe.
The growing awareness regarding animal healthcare is leading the market growth because of the rising initiatives for animal conservation for environmental welfare, along with animal health plays a vital role in the well-being and safety of animals and humans. For instance, the US Department of Agriculture announced a total investment of USD 3 billion in animal health and nutrition in September 2021. In addition, as per the Centers for Disease Control and Prevention, people with age 50 and under age 15 are more prone to develop severe diseases when infected with the eastern equine encephalitis virus (EEEV). Thus, these aforementioned factors are exhibiting a positive influence on market growth. Furthermore, the rising investments by key industry players, as well as increasing expenditure in the equine racing and sports industry are presenting various growth prospects over the foreseen years. However, the reduction in the equine population and dearth of resources in underdeveloped and developing regions stifle market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Equine Healthcare Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the increasing expenditure on healthcare products and services, along with presence of leading market players. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as growing incidences of equine diseases, as well as the rising government support in the regional market.
Major market players included in this report are:
Zoetis Inc.
Boehringer Ingelheim International GmbH
Cev
SOUND
Merck & Co., Inc.
Hallmarq Veterinary Imaging
Esaote SPA
Vetoquinol S.A.
IDEXX Laboratories, Inc.
Dechra Pharmaceuticals PLC
Recent Developments in the Market:
In April 2022, Boehringer Ingelheim International GmbH announced the introduction of RenuTend- a new stem cell therapy. This new launch aims on enhancing the healing of tendon and suspensory ligament injuries in horses.
In September 2022, Zoetis declared the acquisition of NewMetrica, which aims on expanding the company’s companion animal portfolio, by including new health-associated quality-of-life instruments.
Global Equine Healthcare Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product, Indication, Activity, Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Vaccines
Pharmaceuticals
Medicinal Feed Additives
Diagnostics
Software & Services
Others
By Indication:
Musculoskeletal Disorders
Parasite Control
Internal Medicine
Equine Herpes Virus
Equine Influenza
Others
By Activity:
Sports/Racing
Recreation
Others
By Distribution Channel:
Veterinary Hospitals & Clinics
E-commerce
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Equine Healthcare Market, by Region, 2019-2029 (USD Billion)
1.2.2. Equine Healthcare Market, by Product, 2019-2029 (USD Billion)
1.2.3. Equine Healthcare Market, by Indication, 2019-2029 (USD Billion)
1.2.4. Equine Healthcare Market, by Activity, 2019-2029 (USD Billion)
1.2.5. Equine Healthcare Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Equine Healthcare Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Equine Healthcare Market Dynamics
3.1. Equine Healthcare Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of diseases in horses
3.1.1.2. Growing awareness regarding animal healthcare
3.1.2. Market Challenges
3.1.2.1. Reduction in equine population
3.1.2.2. Dearth of resources in underdeveloped and developing regions
3.1.3. Market Opportunities
3.1.3.1. Rising investments by key industry players
3.1.3.2. Increasing expenditure in the equine racing and sports industry
Chapter 4. Global Equine Healthcare Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Equine Healthcare Market, by Product
6.1. Market Snapshot
6.2. Global Equine Healthcare Market by Product, Performance – Potential Analysis
6.3. Global Equine Healthcare Market Estimates & Forecasts by Product 2019-2029 (USD Billion)
6.4. Equine Healthcare Market, Sub Segment Analysis
6.4.1. Vaccines
6.4.2. Pharmaceuticals
6.4.3. Medicinal Feed Additives
6.4.4. Diagnostics
6.4.5. Software & Services
6.4.6. Others
Chapter 7. Global Equine Healthcare Market, by Indication
7.1. Market Snapshot
7.2. Global Equine Healthcare Market by Indication, Performance – Potential Analysis
7.3. Global Equine Healthcare Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
7.4. Equine Healthcare Market, Sub Segment Analysis
7.4.1. Musculoskeletal Disorders
7.4.2. Parasite Control
7.4.3. Internal Medicine
7.4.4. Equine Herpes Virus
7.4.5. Equine Influenza
7.4.6. Others
Chapter 8. Global Equine Healthcare Market, by Activity
8.1. Market Snapshot
8.2. Global Equine Healthcare Market by Activity, Performance – Potential Analysis
8.3. Global Equine Healthcare Market Estimates & Forecasts by Activity 2019-2029 (USD Billion)
8.4. Equine Healthcare Market, Sub Segment Analysis
8.4.1. Sports/Racing
8.4.2. Recreation
8.4.3. Others
Chapter 9. Global Equine Healthcare Market, by Distribution Channel
9.1. Market Snapshot
9.2. Global Equine Healthcare Market by Distribution Channel, Performance – Potential Analysis
9.3. Global Equine Healthcare Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
9.4. Equine Healthcare Market, Sub Segment Analysis
9.4.1. Veterinary Hospitals & Clinics
9.4.2. E-commerce
9.4.3. Others
Chapter 10. Global Equine Healthcare Market, Regional Analysis
10.1. Equine Healthcare Market, Regional Market Snapshot
10.2. North America Equine Healthcare Market
10.2.1. U.S. Equine Healthcare Market
10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
10.2.1.2. Indication breakdown estimates & forecasts, 2019-2029
10.2.1.3. Activity breakdown estimates & forecasts, 2019-2029
10.2.1.4. Distribution Channel breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Equine Healthcare Market
10.3. Europe Equine Healthcare Market Snapshot
10.3.1. U.K. Equine Healthcare Market
10.3.2. Germany Equine Healthcare Market
10.3.3. France Equine Healthcare Market
10.3.4. Spain Equine Healthcare Market
10.3.5. Italy Equine Healthcare Market
10.3.6. Rest of Europe Equine Healthcare Market
10.4. Asia-Pacific Equine Healthcare Market Snapshot
10.4.1. China Equine Healthcare Market
10.4.2. India Equine Healthcare Market
10.4.3. Japan Equine Healthcare Market
10.4.4. Australia Equine Healthcare Market
10.4.5. South Korea Equine Healthcare Market
10.4.6. Rest of Asia Pacific Equine Healthcare Market
10.5. Latin America Equine Healthcare Market Snapshot
10.5.1. Brazil Equine Healthcare Market
10.5.2. Mexico Equine Healthcare Market
10.5.3. Rest of Latin America Equine Healthcare Market
10.6. Rest of The World Equine Healthcare Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Zoetis Inc.
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Boehringer Ingelheim International GmbH
11.2.3. Cev
11.2.4. SOUND
11.2.5. Merck & Co., Inc.
11.2.6. Hallmarq Veterinary Imaging
11.2.7. Esaote SPA
11.2.8. Vetoquinol S.A.
11.2.9. IDEXX Laboratories, Inc.
11.2.10. Dechra Pharmaceuticals PLC
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption
❖ 免責事項 ❖http://www.globalresearch.jp/disclaimer